Sanofi Launches Recommended Cash Offer For Kiadis

(RTTNews) – Sanofi (SNY) said it has made an recommended all-cash offer to all the shareholders to acquire Kiadis Pharma N.V.s’ shares at an offer price of EUR 5.45 (cum dividend) in cash per share, as announced on November 2, 2020. The Offer values 100% of the Shares at about EURead MoreMarketsMarkets Feed